|Bid||39.70 x 1000|
|Ask||39.51 x 1000|
|Day's range||38.97 - 40.09|
|52-week range||33.42 - 46.29|
|Beta (5Y monthly)||0.88|
|PE ratio (TTM)||279.86|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
It hasn't been the best quarter for Boston Scientific Corporation ( NYSE:BSX ) shareholders, since the share price has...
Investors are optimistic about Boston Scientific (BSX) owing to its solid third-quarter performance and impressive value-added acquisitions.
The Zacks Analyst Blog Highlights: Alibaba, Abbott Laboratories, T-Mobile, Anheuser-Busch and Boston Scientific Corp